Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 20, 2025
Reporting Period: Event date May 20, 2025; Signed May 23, 2025
Context: The Company is an emerging growth company incorporated in Delaware, with common stock traded on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding a listing status event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Delisting Notification: On May 20, 2025, the Company received a notification from Nasdaq stating that its securities will be considered for delisting under Listing Rule 5101 (Discretionary Authority).
Reason for Action: Nasdaq staff determined that the issuance of securities in a private placement dated February 27, 2025, specifically the Series A and Series B Warrants, raises public interest concerns. The reset provisions in these warrants could result in substantial dilution for shareholders.
Immediate Consequence: The Nasdaq Hearings Panel will review the matter to determine continued listing status.
Outlook, Risks, and Management Commentary
- Management Response: The Company plans to submit a written response to the Panel by May 30, 2025, and intends to submit a compliance plan.
- Contingency Plan: The Company plans to apply for trading on the OTCQB market (OTC Markets Group Inc.) if the Panel decides to delist the Company from Nasdaq.
- Risks: Forward-looking statements highlight risks regarding the ability to successfully appeal the delisting determination and the ability to secure timely approval for OTCQB trading.
- Unusual Items: The specific concern is the "reset provisions" in the February 2025 private placement warrants, which Nasdaq views as potentially causing excessive shareholder dilution.
Investor Verification Checklist
- Verify the terms of the Series A and Series B Warrants issued in the February 27, 2025 private placement, specifically the reset provisions.
- Monitor the Company's written submission to the Nasdaq Hearings Panel due by May 30, 2025.
- Confirm the status of the Company's application to trade on the OTCQB market.
- Review the "Risk Factors" section of the Company's Annual Report on Form 10-K filed on March 31, 2025, for additional context on delisting risks.